­
A great opportunity for companies creating monitoring devices #digitalhealth. – Elexes
Elexes Medical Consulting

Importance of remote monitoring devices during COVID19 pandemic.

Given that these devices allow patients to timely get the necessary care and/or advice, while still practicing physical distancing and easing the burden on hospitals and health care professionals, they are of huge value.

The #fda is allowing, without a prior approval, modifications to:

1. FDA cleared non-invasive monitoring #medicaldevices in response to the COVID-19 public health emergency, as long as the modifications do not create any undue risk.

2. Devices that allow for increased #remotemonitoring capability as long as the modifications do not directly affect the physiological parameter measurement algorithms.

3. Existing technology for an application to more closely monitor the COVID-19 patients.

Companies making monitoring devices #telehealth can take advantage of the current flexibility and provisions to facilitate patient care. #510 #elexes

Leave a Reply




You may also like

Medical Devices

Clinical trials in South Africa – worldwide accepted data

Clinical trials being a resource, cost, and time extensive process, identifying the right location for a clinical trial

Medical Devices

RUO – A Market Opportunity for IVD companies

Getting an IVD product to the market is a cumbersome task and takes several months to over a year to finally get everyth

Medical Devices

Official Number is now 15 – MDD to MDR + IVDD to IVDR Planning

Everyone knows that the advent of MDR was postponed, and the new regulation shall be in full force from May 26, 2021. As

Medical Devices

Who regulates your products?

The first step towards bringing your product to the market is understanding which center at the FDA shall regulate your